Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections

(1) Objectives: To describe the relationship between pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) piperacillin–tazobactam or meropenem monotherapy and microbiological outcome in a case series of urological patients with documented Gram-negative infections. (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Berrino, Pasquale Maria, Gatti, Milo, Rinaldi, Matteo, Brunocilla, Eugenio, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525318/
https://www.ncbi.nlm.nih.gov/pubmed/37760685
http://dx.doi.org/10.3390/antibiotics12091388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525318/
https://www.ncbi.nlm.nih.gov/pubmed/37760685
http://dx.doi.org/10.3390/antibiotics12091388

Ejemplares similares